DNA testing companies agree to new data sharing rules

Amy Baxter | | Health Exec | Cybersecurity

Genetic testing companies—including Ancestry and 23andMe—have agreed to new rules when it comes to sharing customers’ DNA with third-party companies, Fortune reported.

The new guidelines require the companies to receive “express consent” before providing genetic information to other companies, researchers or authorities. The new rules follow privacy warning issued by the Federal Trade Commission on the services.

The agreement comes just as 23andMe penned a $300 million contract with GlaxoSmithKline to allow access to the genetic information of 23andMe’s five million customers.

Read the full story below:

Ancestry and 23andMe Agree to Rules on Providing DNA to Third Parties

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Healthcare hacker sentenced to 10 years in prison
Ransomware group deploys ticking clock to threaten Georgia hospital
Hackers were inside an Iowa hospital’s network for two weeks
Microsoft: Ransomware hit nearly 400 healthcare entities this year—a 300% rise since 2015
Feds make it official: Change data breach was the largest in healthcare history, impacting 100M
CMS contractor takes $1.2M loss after data breach, DOJ lawsuit

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup